Getting the most out of First-in-Human and Early Clinical Trials

In a follow-up to our webinar last month on first-in-human drug studies, FierceBiotech editor, John Carroll is hosting a second discussion on the increasing complexity of first-in-human/early clinical pharmacology studies. Three trial experts will present real-life case studies of trials that went well beyond the standard safety and PK assessments in typical FIH studies is recommended. Register now.